Tímea Gurbity Pálfi

Screening and monitoring of the BTKC481S mutation in a real‐world cohort of patients with relapsed/refractory chronic lymphocytic leukaemia during ibrutinib therapy

P. Csermely, L. Gergely, E. Sebestyén, 2021, British journal of haematology.

[State of the art molecular diagnostics and therapy of chronic lymphocytic leukaemia in the era of new targeted therapies].

Z. Borbényi, C. Bödör, Csaba Bödör, 2017, Orvosi hetilap.